Pyridopyrimidinone derivatives for treatment of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/505 (2006.01) A61P 25/28 (2006.01) C07D 221/00 (2006.01) C07D 239/00 (2006.01)

Patent

CA 2394525

This invention provides a method for treating neurodegenerative diseases in mammals comprising administering an effective amount of a cyclin-dependent kinase inhibitor. A preferred method uses cdk inhibitors of Formula (I) and Formula (II) where W is NH, S, SO, or SO2, R1 includes phenyl and substituted phenyl, R2 includes alkyl and cycloalkyl, R3 includes alkyl and hydrogen, R8 and R9 include hydrogen and alkyl, and Z is carboxy.

L'invention concerne un procédé permettant de traiter les maladies neurodégénératives chez les mammifères. Ce procédé consiste à administrer une quantité efficace d'un inhibiteur de kinase dépendante des cyclines. Un mode de réalisation optimal consiste à utiliser des inhibiteurs de kinase dépendante des cyclines représentés par la formule (I) et par la formule (II). Dans ces formules, W représente NH, S, SO, ou SO¿2?, R?1¿ comprend un phényle et un phényle substitué, R?2¿ comprend un alkyle et un cycloalkyle, R?3¿ comprend un alkyle et un hydrogène, R?8¿ et R?9¿ comprennent un hydrogène et un alkyle, et Z représente carboxy.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyridopyrimidinone derivatives for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridopyrimidinone derivatives for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridopyrimidinone derivatives for treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1500749

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.